Assignment of Assignor's Interest

Recorded: 2024-06-27 Pages: 20

Assignor

OSIRIS THERAPEUTICS, INC.

Executed: 2013-10-10

Assignee

MESOBLAST INTERNATIONAL SÁRL

ROUTE DE PRE-BOIS 20, MEYRIN, 1217, SWITZERLAND

Covered Property (1)

Mesenchymal Stem Cells Expressing Tnf-Alpha Receptors

Application: 18/484,347 →

Publication: US 2024/0301356

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.